Paper30463570
LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.
Liu H and 4 others. J Exp Clin Cancer Res, 2018. Cited by 250 papers, by iCite.
Cite this record
ConductScience Library. LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. Papers, record 30463570. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30463570
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| MicroRNAs | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| Proto-Oncogene Proteins c-met | Major topic |
| RNA, Long Noncoding | Major topic |
| Thyroid Neoplasms | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Female | |
| Humans | |
| Mice | |
| Mice, Nude | |
| Middle Aged | |
| Signal Transduction | |
| Transfection |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26871295 | miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/26871295 | PubMed |
| 2 | 19352602 | MicroRNA expression profiles in thyroid tumors. | Endocr Pathol | 2009 | https://conductscience.org/library/papers/19352602 | PubMed |
| 3 | 27347178 | Long noncoding RNA are aberrantly expressed in human papillary thyroid carcinoma. | Oncol Lett | 2016 | https://conductscience.org/library/papers/27347178 | PubMed |
| 4 | 11057895 | Cell signaling by receptor tyrosine kinases. | Cell | 2000 | https://conductscience.org/library/papers/11057895 | PubMed |
| 5 | 25366139 | A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer. | Tumour Biol | 2015 | https://conductscience.org/library/papers/25366139 | PubMed |
| 6 | 23276957 | MicroRNA role in thyroid cancer pathogenesis. | Front Biosci (Landmark Ed) | 2013 | https://conductscience.org/library/papers/23276957 | PubMed |
| 7 | 25578780 | Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152. | Cancer Lett | 2015 | https://conductscience.org/library/papers/25578780 | PubMed |
| 8 | 3600795 | A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. | Nature | 1987 | https://conductscience.org/library/papers/3600795 | PubMed |
| 9 | 29254219 | LncRNA MALAT1 acts as an oncogene in multiple myeloma through sponging miR-509-5p to modulate FOXP1 expression. | Oncotarget | 2017 | https://conductscience.org/library/papers/29254219 | PubMed |
| 10 | 28831025 | LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway. | Biosci Rep | 2017 | https://conductscience.org/library/papers/28831025 | PubMed |
| 11 | 25524864 | LncTar: a tool for predicting the RNA targets of long noncoding RNAs. | Brief Bioinform | 2015 | https://conductscience.org/library/papers/25524864 | PubMed |
| 12 | 28670492 | The long non-coding RNA HOTAIR promotes thyroid cancer cell growth, invasion and migration through the miR-1-CCND2 axis. | Am J Cancer Res | 2017 | https://conductscience.org/library/papers/28670492 | PubMed |
| 13 | 28617552 | Long non-coding RNA TUG1 can promote proliferation and migration of pancreatic cancer via EMT pathway. | Eur Rev Med Pharmacol Sci | 2017 | https://conductscience.org/library/papers/28617552 | PubMed |
| 14 | 28645161 | LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. | Acta Biochim Biophys Sin (Shanghai) | 2017 | https://conductscience.org/library/papers/28645161 | PubMed |
| 15 | 23349248 | Recent insights into the cell biology of thyroid angiofollicular units. | Endocr Rev | 2013 | https://conductscience.org/library/papers/23349248 | PubMed |
| 16 | 24519926 | Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. | Oncotarget | 2014 | https://conductscience.org/library/papers/24519926 | PubMed |
| 17 | 28893349 | WITHDRAWN: LncRNA-HOTAIR Activates Tumor Cell Proliferation and Migration by Suppressing MiR-326 in Cervical Cancer. | Oncol Res | 2017 | https://conductscience.org/library/papers/28893349 | PubMed |
| 18 | 28524153 | Transcriptome analysis of miRNA-lncRNA-mRNA interactions in the malignant transformation process of gastric cancer initiation. | Cancer Gene Ther | 2017 | https://conductscience.org/library/papers/28524153 | PubMed |
| 19 | 22664915 | The hallmarks of cancer: a long non-coding RNA point of view. | RNA Biol | 2012 | https://conductscience.org/library/papers/22664915 | PubMed |
| 20 | 28838947 | Key signaling pathways in thyroid cancer. | J Endocrinol | 2017 | https://conductscience.org/library/papers/28838947 | PubMed |
Cited by184
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 250 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42677088 | Non-coding RNAs related to PD1/PD-L1 signaling with potential diagnostic, prognostic, and therapeutic value in the tumorigenesis of brain cancers. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42677088 | PubMed |
| 42172440 | Transcriptional programs diverge in aging mouse and human skeletal muscle. | Aging (Albany NY) | 2026 | https://conductscience.org/library/papers/42172440 | PubMed |
| 41800331 | LncRNA VCAN-AS1 Sponges miR-374c-3p to Promote Proliferation, Invasion, Migration, and EMT in Thyroid Cancer. | Int J Endocrinol | 2026 | https://conductscience.org/library/papers/41800331 | PubMed |
| 41601966 | X-inactive specific transcript (XIST) can determine sex differences in cardiovascular drug responses: focus on RNA therapeutics. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41601966 | PubMed |
| 41430272 | Xist in X chromosome inactivation: mechanisms and disease relevance. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/41430272 | PubMed |
| 41386982 | Transcription and potential functions of a novel XIST isoform in male peripheral glia. | Genome Res | 2026 | https://conductscience.org/library/papers/41386982 | PubMed |
| 41154428 | The Interplay Between lncRNAs-microRNAs Network Dysregulation and Cellular Hallmarks of Thyroid Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41154428 | PubMed |
| 41153882 | Exosomal miRNAs Mediate Immune-Metabolic Interactions in the Hemocytes of the Pearl Oyster Pinctada fucata martensii. | Animals (Basel) | 2025 | https://conductscience.org/library/papers/41153882 | PubMed |
| 40919257 | Involvement of lncRNA in cancer diagnosis and prognosis and clinical implications. | Rep Pract Oncol Radiother | 2025 | https://conductscience.org/library/papers/40919257 | PubMed |
| 40702513 | Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches. | Infect Agent Cancer | 2025 | https://conductscience.org/library/papers/40702513 | PubMed |
| 40594499 | DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway. | Sci Rep | 2025 | https://conductscience.org/library/papers/40594499 | PubMed |
| 40069775 | Reprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40069775 | PubMed |
| 40015977 | Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer. | Aging (Albany NY) | 2025 | https://conductscience.org/library/papers/40015977 | PubMed |
| 39720352 | Non-coding RNAs and regulation of the PI3K signaling pathway in lung cancer: Recent insights and potential clinical applications. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/39720352 | PubMed |
| 39570470 | Nanoparticles (NPs)-meditated si-lncRNA NONHSAT159592.1 inhibits glioblastoma progression and invasion through targeting the ITGA3/FAK/PI3K/AKT pathway. | Metab Brain Dis | 2024 | https://conductscience.org/library/papers/39570470 | PubMed |
| 39552712 | LINC00261 triggers DNA damage via the miR-23a-3p/CELF2 axis to mitigate the malignant characteristics of 131I-resistant papillary thyroid carcinoma cells. | Biochem Biophys Rep | 2024 | https://conductscience.org/library/papers/39552712 | PubMed |
| 39518984 | Colon Cancer-Derived Exosomal LncRNA-XIST Promotes M2-like Macrophage Polarization by Regulating PDGFRA. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39518984 | PubMed |
| 39458944 | Tight Junctions and Cancer: Targeting Claudin-1 and Claudin-4 in Thyroid Pathologies. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39458944 | PubMed |
| 39296640 | Emerging roles of non-coding RNAs in modulating the PI3K/Akt pathway in cancer. | Noncoding RNA Res | 2025 | https://conductscience.org/library/papers/39296640 | PubMed |
| 39149142 | Non-coding RNAs as therapeutic targets in cancer and its clinical application. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/39149142 | PubMed |
Genes20
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30463570
GET https://conductscience.org/api/papers/v1/30463570/references?page=2